BM
ELGX

Bridger Management’s Endologix Inc ELGX Stock Holding History

Bridger Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-67,542
Closed -$8.28M – 46
2015
Q3 		$8.28M Buy
+67,542
New +$9.17M 0.56% 33

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bridger Management's ELGX Position: Q4 2015 in Review

Bridger Management sold out of Endologix Inc (ELGX) in Q4 2015, closing a stake of 67,542 shares — an estimated $8.28M sold.

Bridger Management first reported a position in ELGX in Q3 2015 and held it in 1 quarter. The position peaked at $8.28M in Q3 2015. 128 funds tracked by Wall St. Rank hold ELGX as of Q4 2015.

  • Bridger Management reported no remaining Endologix Inc position as of Q4 2015 after selling out during the quarter.
  • Bridger Management sold 67,542 Endologix Inc shares in Q4 2015, an estimated $8.28M.
  • Bridger Management first reported a position in Endologix Inc in Q3 2015 and held it in 1 quarter.
  • Bridger Management's Endologix Inc position peaked at $8.28M in Q3 2015.
  • 128 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2015.

Based on Bridger Management's 13F filing for Q4 2015, filed 16 Feb 2016.